An interventional study of osteopathic manipulative medicine (OMM) in Otitis Media With Effusion, sponsored by West Virginia School of Osteopathic Medicine. Completed at 2 sites in United States. Open to participants aged 6 Months to 2 Years. Per ClinicalTrials.gov, last updated 2018-03-26.
Sponsored by West Virginia School of Osteopathic Medicine · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Otitis Media with Effusion with a site in United States — 7 open to participants now, 8 under way, none of them phase 3. Otitis Media with Effusion · United States.
Among the 27 studies in Otitis Media with Effusion with a site in United States, this one is the 13th largest by enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2007, is one of 10 with no phase, and was the 5th registered.
88 studies on the registry are indexed under Otitis Media with Effusion; 17 are open to participants now.
Browse Otitis Media with Effusion studies →7 of the 27 studies in Otitis Media with Effusion with a site in United States are open now. Recruiting first, the newest first:
ClinQure, Inc. · Sites in United States
Ages 6 mo+
Stanford University · Sites in United States
Ages 1–17
Smith & Nephew, Inc. · Sites in United States
Ages 6 mo–17 yrs
Medical College of Wisconsin · Sites in United States
Ages 12 mo–6 yrs
Philip Perez · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 8 Otitis Media with Effusion studies recruiting now, 1 sets no upper age limit and 7 stop at 75 or younger; 8 take children under 18; 2 take healthy volunteers.
This study: 6 Months to 2 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 7 · Phase 4 1
First in 1997; this study’s year is marked. 2 started in 2007.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 52 is below the median of 80 across 61 interventional studies indexed under Otitis Media with Effusion.
Median enrollment 82 across the 20 interventional studies, 194 across the 6 observational. Of the 17 that completed or were terminated, 12 (71%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 27 have an industry lead sponsor. The 10 most frequent:
West Virginia School of Osteopathic Medicine is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
West Virginia School of Osteopathic Medicine has 1 study filed under Otitis Media with Effusion — fewer than ten, so there is no comparison to draw.
4 of the studies in Otitis Media with Effusion with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05353569Medical College of WisconsinCoherent Optical Detection of Middle Ear Disease | 2027-04 |
| NCT06944795Stanford UniversitySWIR Otoscopy Study | 2027-04-30 |
| NCT07625657ClinQure, Inc.CLIKX® Tympanostomy Tube Delivery System for the Placement of Tympanostomy Tubes | 2027-06 |
| NCT07777302Philip PerezEarFlo: A Non-Invasive Treatment for Otitis Media With Effusion & Eustachian Tube Dysfunction in Adults | 2027-11-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 27 studies in Otitis Media with Effusion with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine if the application of osteopathic manipulative medicine speeds the rate of resolution of middle ear effusion (fluid) in children following an episode of acute otitis media.
Acute otitis media is a significant world wide problem commonly affecting children between 6 and 18 months, and is the most frequent reason for childhood illness visits to a physician in the US. By three years of age, 50-70% of children will have had one episode, while one-third will have had more than three. Persistence of middle ear effusion following an episode of acute otitis media is thought to predispose the child to recurrent infection. The standard care for recurrent acute otitis media includes long term antibiotic prophylaxis and surgery. The risks of standard care are recognized, and alternative means of treating acute disease and preventing recurrent otitis media are needed.
For over a century, osteopathic physicians have reported favorable clinical outcomes in children treated with osteopathic manipulative medicine (OMM) in addition to standard medical care. To determine if a standardized OMM protocol will reduce the duration of middle ear effusion (MEE) after onset of acute otitis media, we outline a prospective, randomized, blinded, multi-center efficacy study of children ages six months to two years with a single episode of acute otitis media. Subjects will be randomized into one of two treatment groups: standard care plus OMM and standard care only. Subjects will be followed for one month to determine rate of resolution of middle ear effusion following onset of the acute otitis media. Statistical analysis will determine any differences between subjects in the two treatment groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Subjects will receive active intervention with osteopathic manipulative medicine (OMM) using a prescribed standardized treatment protocol which is age appropriate. Subjects will also receive standard care for otitis media from their referring physician.
Procedure: osteopathic manipulative medicine (OMM)
Subjects will receive standard care only for otitis media from their regular referring physician
At each of the first three study visits, all subjects in the osteopathic manipulative medicine (OMM) group will receive OMM using the prescribed protocol.
Change in Middle Ear Effusion Over Four Weeks Following an Episode of Acute Otitis Media
For this study, the tympanogram was chosen to measure middle ear effusion. Three tympanogram readings from each ear included in the study were taken at the beginning of each of 5 Study Visits. For the intervention group, a second set of 3 tympanograms was taken immediately after the OMM on Visits 1, 2 and 3. All tympanograms were sent to a blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed from baseline over 4 weeks was computed by crosstabulating the intervention group by the normal/abnormal changes in tympanograms.
Time frame: 1 month
Change in Middle Ear Effusion Immediately After OMM at Study Visit 2
For this study, the tympanogram was chosen to measure middle ear effusion. For the SC+OMT Group during study visit 2, three tympanogram readings from each ear included in the study were taken prior to, and immediately after the intervention. The tympanograms were sent to the blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed between "normal" and "abnormal" from before and after the OMM was computed.
Time frame: Before and immediately after OMM at study visit 2
Change in Middle Ear Effusion Immediately After OMM at Study Visit 3
For this study, the tympanogram was chosen to measure middle ear effusion. For the SC+OMT Group during study visit 3, three tympanogram readings from each ear included in the study were taken prior to, and immediately after the intervention. The tympanograms were sent to the blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed between "normal" and "abnormal" from before and after the OMM was computed.
Time frame: Before and immediately after OMM at study visit 3
Recruitment dates: September 2007 through May 2009 Site: medical clinics of 2 colleges of osteopathic medicine Location: mid-Atlantic and Northeast areas of the United States
| Milestone | Standard Care Plus OMM (SC+OMM) | Standard Care Only (SCO) |
|---|---|---|
| Started | 28 | 24 |
| Completed | 21 | 19 |
| Not completed | 7 | 5 |
| Withdrew: Exclusion criteria met at first visit | 7 | 5 |
For this study, the tympanogram was chosen to measure middle ear effusion. Three tympanogram readings from each ear included in the study were taken at the beginning of each of 5 Study Visits. For the intervention group, a second set of 3 tympanograms was taken immediately after the OMM on Visits 1, 2 and 3. All tympanograms were sent to a blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed from baseline over 4 weeks was computed by crosstabulating the intervention group by the normal/abnormal changes in tympanograms.
| Ears | Standard Care Plus OMM (SC+OMM) | Standard Care Only (SCO) |
|---|---|---|
| Improvement in MEE at 2 weeks | 26 | 16 |
| No Improvement in MEE at 2 weeks | 12 | 22 |
For this study, the tympanogram was chosen to measure middle ear effusion. For the SC+OMT Group during study visit 2, three tympanogram readings from each ear included in the study were taken prior to, and immediately after the intervention. The tympanograms were sent to the blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed between "normal" and "abnormal" from before and after the OMM was computed.
| ears | Before OMM | After OMM |
|---|---|---|
| Resolution of MEE after OMM at Visit 2 | 5 | 6 |
| No Resolution of MEE at end of OMM at visit 2 | 26 | 23 |
For this study, the tympanogram was chosen to measure middle ear effusion. For the SC+OMT Group during study visit 3, three tympanogram readings from each ear included in the study were taken prior to, and immediately after the intervention. The tympanograms were sent to the blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed between "normal" and "abnormal" from before and after the OMM was computed.
| ears | Before OMM | After OMM |
|---|---|---|
| Resolution of MEE at Visit 3 | 12 | 13 |
| No Resolution of MEE after OMM at Visit 3 | 19 | 25 |
Collected over 1month. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Standard Care Plus OMM | — | 0/28 (0%) | 0/28 (0%) |
| Standard Care Only | — | 0/24 (0%) | 0/24 (0%) |
52 participants were enrolled and 12 excluded due to normal tympanograms at first study visit, leaving 19 subjects in the SCO and 21 subjects in the SC+OMM group.
| Age, Categorical(Participants) | Standard Care Plus OMM | Standard Care Only | Total |
|---|---|---|---|
| <=18 years | 28 | 24 | 52 |
| Between 18 and 65 years | 0 | 0 | 0 |
| >=65 years | 0 | 0 | 0 |
| Sex: Female, Male(Participants) | Standard Care Plus OMM | Standard Care Only | Total |
|---|---|---|---|
| Female | 12 | 11 | 23 |
| Male | 16 | 13 | 29 |
| Region of Enrollment(participants) | Standard Care Plus OMM | Standard Care Only | Total |
|---|---|---|---|
| United States | 28 | 24 | 52 |
Plan to share: No
The record gives a start of Sep 2007, a primary completion of Aug 2009 and a completion of Aug 2009. It does not say whether these dates are actual or estimated.
Results were first posted in Mar 2018, 8 years 7 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
West Virginia School of Osteopathic Medicine